Tamayo, Aimie .
HRN: 23-61-00 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2025
CEFUROXIME 500MG (TAB)
12/10/2025
12/17/2025
PO
500mg
BID
S/P PLTCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes